pus840
发表于 2025-3-28 15:32:05
http://reply.papertrans.cn/23/2212/221125/221125_41.png
对待
发表于 2025-3-28 20:37:14
http://reply.papertrans.cn/23/2212/221125/221125_42.png
货物
发表于 2025-3-29 02:37:48
The Systemic Effects of Recent Regionalismerapies used for treatment in both non-muscle invasive and muscle-invasive bladder cancer (NMIBC and MIBC). Perhaps the most well-known immunotherapy used for bladder cancer is intravesical BCG immunotherapy, which remains to be the standard treatment in intermediate- and high-risk NMIBC. However, r
Graves’-disease
发表于 2025-3-29 04:43:38
http://reply.papertrans.cn/23/2212/221125/221125_44.png
解开
发表于 2025-3-29 08:33:44
http://reply.papertrans.cn/23/2212/221125/221125_45.png
浪荡子
发表于 2025-3-29 11:34:37
https://doi.org/10.1057/9780230377561elicit and enhance a therapeutic antitumoral response. In this chapter, an overview of the intricacies of the immune system in the CNS within the context of tumor immunology is presented. In addition, some of the most salient immunotherapeutic advances for treatment of CNS tumors are explored.
MIME
发表于 2025-3-29 16:55:07
Immunotherapy in Nonmelanoma Skin Cancers,It works by boosting the host’s immune system against tumoral cells and has the advantage of being noninvasive and having the potential to prevent future malignancies. Herein the several types of immunotherapy have been explored including intralesional interferons and interleukins, cancer vaccines, check pint inhibitor antibodies, and virotherapy.
破译
发表于 2025-3-29 22:26:00
http://reply.papertrans.cn/23/2212/221125/221125_48.png
Mosaic
发表于 2025-3-30 01:09:17
Immunotherapy for Pediatric Solid Tumors,ts, the results are promising even in patients with advanced disease and should be explored further. In this chapter, we review the different immunotherapeutic approaches that have been and are being evaluated in the pediatric oncology setting.
肉身
发表于 2025-3-30 04:31:21
Immunopathology and Immunotherapy of Hodgkin Lymphoma,eloped in recent years, which are still at their infancy. Since correct understanding of the underlying immunopathology seems inevitable in efficient immunotherapy and development of future techniques, a brief description with the emphasis on suitable targets for immunotherapy is given before discussing various immunotherapies.